BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rust C, Gores GJ. Locoregional management of hepatocellular carcinoma. Surgical and ablation therapies. Clin Liver Dis. 2001;5:161-173. [PMID: 11218913 DOI: 10.1016/s1089-3261(05)70159-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Minami Y, Kudo M. Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma. World J Gastroenterol 2011; 17(45): 4952-4959 [PMID: 22174544 DOI: 10.3748/wjg.v17.i45.4952] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
2 Primrose JN. Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation. Gut 2002;50:1-5. [PMID: 11772955 DOI: 10.1136/gut.50.1.1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
3 Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: Current status. World J Radiol 2010; 2(11): 417-424 [PMID: 21179308 DOI: 10.4329/wjr.v2.i11.417] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
4 Yin JM, Sun LB, Zheng JS, Wang XX, Chen DX, Li N. Copper chelation by trientine dihydrochloride inhibits liver RFA-induced inflammatory responses in vivo. Inflamm Res 2016;65:1009-20. [PMID: 27613237 DOI: 10.1007/s00011-016-0986-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
5 Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: Current status. World J Radiol. 2010;2:417-424. [PMID: 21179308 DOI: 10.4329/wjr.v2.ill.417] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Lin LW, Lin XY, He YM, Gao SD, Xue ES, Lin XD, Yu LY. Experimental and clinical assessment of percutaneous hepatic quantified ethanol injection in treatment of hepatic carcinoma. World J Gastroenterol 2004; 10(21): 3112-3117 [PMID: 15457554 DOI: 10.3748/wjg.v10.i21.3112] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Choi EJ, Choi YM, Kim HJ, Ok HG, Chang EJ, Kim HY, Yoon JU, Kim KH, Byeon GJ. The Effects of Thoracic Epidural Analgesia during Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma. Pain Res Manag. 2018;2018:4354912. [PMID: 30581515 DOI: 10.1155/2018/4354912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Macedo G, Lopes S, Barroso S, Costa-Maia J, de Matos N. Hepatocellular carcinoma in orthotopic liver transplantation candidates. Transplant Proc 2003;35:1113-4. [PMID: 12947879 DOI: 10.1016/s0041-1345(03)00329-4] [Reference Citation Analysis]
9 Nanashima A, Masuda J, Miuma S, Sumida Y, Nonaka T, Tanaka K, Hidaka S, Sawai T, Nagayasu T. Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score. World J Gastroenterol 2008; 14(1): 58-63 [PMID: 18176962 DOI: 10.3748/wjg.14.58] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
10 Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Aker S, Yilmaztepe A, Gurel S, Gulten M, Nak SG. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol 2007; 13(6): 837-844 [PMID: 17352011 DOI: 10.3748/wjg.v13.i6.837] [Cited by in CrossRef: 123] [Cited by in F6Publishing: 112] [Article Influence: 8.2] [Reference Citation Analysis]
11 Orlacchio A, Bolacchi F, Chegai F, Bergamini A, Costanzo E, Del Giudice C, Angelico M, Simonetti G. Comparative evaluation of percutaneous laser and radiofrequency ablation in patients with HCC smaller than 4 cm. Radiol Med. 2014;119:298-308. [PMID: 24277510 DOI: 10.1007/s11547-013-0339-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
12 Chen QW, Teng WJ, Chen Q. Chest wall hernia induced by high intensity focused ultrasound treatment of unresectable massive hepatocellular carcinoma: A case report. Oncol Lett 2016;12:627-30. [PMID: 27347191 DOI: 10.3892/ol.2016.4618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
13 Silverman PM, Szklaruk J. Controversies in imaging of hepatocellular carcinoma: multidetector CT (MDCT). Cancer Imaging 2005;5:178-87. [PMID: 16361147 DOI: 10.1102/1470-7330.2005.0105] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
14 Bimonte S, Leongito M, Piccirillo M, de Angelis C, Pivonello C, Granata V, Izzo F. Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment. Infect Agent Cancer 2016;11:38. [PMID: 27525037 DOI: 10.1186/s13027-016-0082-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
15 Giannini E, Testa R. Surveillance for hepatocellular carcinoma in liver cirrhosis: have programmes improved because patients have? Gut 2002;51:456-7. [PMID: 12171975 DOI: 10.1136/gut.51.3.456-a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: a literature review. Int J Hepatol. 2011;2011:104685. [PMID: 21994847 DOI: 10.4061/2011/104685] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 4.9] [Reference Citation Analysis]